Form 8-K - Current report:
SEC Accession No. 0000950170-24-130263
Filing Date
2024-11-22
Accepted
2024-11-22 16:49:38
Documents
11
Period of Report
2024-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K amrn-20241122.htm   iXBRL 8-K 47994
  Complete submission text file 0000950170-24-130263.txt   176293

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20241122.xsd EX-101.SCH 32939
14 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20241122_htm.xml XML 5115
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 241490565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)